Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

156.01 -9.83 (-5.93%)
Streaming Delayed Price Updated: 1:19 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,248,814
Open 160.73
Bid (Size) 155.99 (2)
Ask (Size) 156.01 (1)
Prev. Close 165.84
Today's Range 155.95 - 161.81
52wk Range 140.68 - 169.99
Shares Outstanding 2,628,679,824
Dividend Yield 3.18%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wall Street Inches Up Ahead Of Tariff Day: What's Driving Markets Tuesday?
Following the worst quarterly performance for U.S. stocks in over two years, caution dominated Wall Street as investors awaited details on the tariff plans expected from the Trump administration on... 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
These S&P500 stocks are gapping in today's session
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends. 
Via Chartmill

Performance

YTD
+8.3%
+8.3%
1 Month
-6.7%
-6.7%
3 Month
+8.8%
+8.8%
6 Month
-3.7%
-3.7%
1 Year
-1.1%
-1.1%

More News

Read More
Why Johnson & Johnson (JNJ) Shares Are Falling Today
Via StockStory
Topics Bankruptcy Lawsuit
Exposures Financial Legal
US Manufacturing Slips Into Contraction As Tariff-Driven Costs Hit Near 3-Year High
Via Benzinga
These S&P500 stocks are moving in today's pre-market session
Via Chartmill
J&J Dives After Judge Tosses Out $10 Billion Talc-Based Bankruptcy Plan
Via Investor's Business Daily
Topics Bankruptcy Lawsuit
Exposures Financial Legal
US Judge Rejects Another Johnson & Johnson Attempt To Use Bankruptcy For Talc Cancer Claims
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal
Federal Judge Rejects Johnson & Johnson Bankruptcy Strategy, Paving Way for Talc Victims to Seek Justice in Trial Courts
From Beasley Allen Law Firm
Via Business Wire
2 Value Stocks I'm Buying Right Now
Via The Motley Fool
Topics Economy
Exposures Interest Rates
Johnson & Johnson to Return to Tort System to Defeat Meritless Talc Claims
From Johnson & Johnson
Via Business Wire
Value Stocks Gain Ground As Inflation, Recession Fears Grow: 4 ETFs To Capitalize On The Trend
Via Benzinga
Topics ETFs Economy
Exposures Economy Interest Rates
1 Healthcare Stock to Target This Week and 2 to Turn Down
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Is Hims & Hers Stock Too Cheap to Pass Up?
Via The Motley Fool
3 Relatively Safe Stocks to Buy Right Now
Via The Motley Fool
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Elliott Wave Technical Analysis: Johnson & Johnson - Friday, March 28
Via Talk Markets
Topics Stocks / Equities
Investors Are Flocking to These 3 Vanguard Sector ETFs. Should You Buy Them Too?
Via The Motley Fool
Topics ETFs Economy Government
Exposures Economy Political Tariff
2 Reasons to Like JNJ and 1 to Stay Skeptical
Via StockStory
Topics Supply Chain
Exposures Supply Chain
What Rare Earth Minerals Does Ukraine Have?
Via MarketMinute
Topics Economy Electric Vehicles Emissions
Exposures Economy Electric Vehicles Fossil Fuels
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Via Investor's Business Daily
Topics Government
Exposures Political
2 Recession-Proof Dividend Stocks to Buy and Hold
Via The Motley Fool
J&J Drug Combo Outperforms Leading Lung Cancer Treatment In Survival Study
Via Benzinga
Kenvue Stock In Focus As TOMS Capital Reportedly Pushes For Sale Or Breakup: Will It Shift Retail Mood?
Via Stocktwits
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
Via Benzinga
FDA Approves Johnson & Johnson's Tremfya For Crohn's Disease
Via Benzinga
Exposures Product Safety
Johnson & Johnson To Invest $55 Billion In US To Boost Manufacturing, Drug Discovery
Via Benzinga

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 156.01
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 04/01/25 01:19 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 410.10B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 410B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.